A New Mode of Action of Anti-TNF, Reverse Signaling, in Rheumatoid Arthritis

NCT03216928 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
33
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University Hospital, Toulouse